Dr. Laura Sena, MD

Dr. Sena practices at The Johns Hopkins Hospital in Baltimore, Maryland, part of Johns Hopkins Health System.

Dr. Sena's NPI, 1467841130, was assigned on January 17, 2015. Dr. Sena holds Maryland license D85649.

Dr. Sena's primary practice is The Johns Hopkins Hospital, at 600 North Wolfe Street, Baltimore, MD 21287 in Baltimore City. The practice phone is (410) 955-9540.

Dr. Sena's primary practice is The Johns Hopkins Hospital in Baltimore, Maryland, part of Johns Hopkins Health System. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Sena to 1 more group practice or clinic, 1 therapy and rehab clinic and 1 medical group, each named with a free account. Dr. Sena's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sena practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Sena's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Sena is licensed in Maryland.

CMS data shows 216 Medicare services from Dr. Sena across 3 procedure codes in 2024, for 70 Medicare patients. Medicare paid $12,877 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 70 Medicare patients who saw Dr. Sena in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have cancer, and 73% have high blood pressure. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sena's median patient age at 73, with 2% women.

In 2024, Dr. Sena wrote 335 Medicare Part D claims for 32 patients. 72% of them were for generic drugs. CMS names the drug for 262 of them, across 7 drugs with 11 or more claims each, at $976,100 in total drug cost. In 2023, CMS named 112 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Sena for performance year 2024, reported as part of a group. CMS lists Dr. Sena as offering telehealth.

Dmand AI links 26 papers to Dr. Sena, published from 2013 to 2025. 2024 was the busiest year, with 7. The most frequent topics are Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant and Androgens. Dr. Sena has published most often in Prostate. Dr. Sena's most frequent co-authors are Samuel Ray Denmeade, MD, Mark Christopher Markowski, MD, PhD and Channing Paller, MD.